Metabolomics Biomarkers of Neurodegeneration

Client

Corewell Health is a not-for-profit health system that provides health care and coverage with an exceptional team of 65,000+ dedicated people, including more than 12,000 physicians and advanced practice providers and more than 15,500 nurses providing care and services in 21 hospitals, 300+ outpatient locations and several post-acute facilities, and Priority Health, a provider-sponsored health plan serving more than 1.3 million members.

Background

Identify small molecules that could be used for diagnostics of various neurological conditions and neurodegenerative disorders.

Solutions

  • Targeted and untargeted mass spectrometry data processing pipeline
  • Integration of metabolomics, epigenomics and other data sources
  • AI-based predictors for diagnostics and identification of novel therapeutic targets

Publications

Scientific Reports, read full article: Link
Genes, read full article: Link

Cover image credits: Anusorn / Adobe Stock

Similar Resources

rAAVen Therapeutics
Success stories
July 8, 2026

Needles in Haystacks – How VUGENE Is Finding the Right Adeno-Associated Viruses to Deliver Gene Therapy

WATCH – Customer success story | rAAVen Therapeutics Background Adeno-associated viral vectors, or AAVs, are viruses that can transport therapeutic genes into the body for gene therapy. AAV2, for ...

The Epigenetic Clock Development Foundation
Success stories
July 8, 2026

Age Is More Than Just a Number – How VUGENE Is Enabling Measurement of the Biological Clock

WATCH – Customer success story | The Epigenetic Clock Development Foundation Background Over the course of a human’s life, their DNA is exposed to a plethora of epigenetic modulators. ...